General

Ethics & Sciences – Creating SARS

Hazards of creating pathogens - SARS

In 2015 scientists sent people into caves to gather a RsSHC014-CoV from Chinese horseshoe bats – where the threat of spread to humans was minimal. They brought it back to the lab, created Frankenmice with human lung tissue to amplify and build a chimeric virus encoding a new “novel” zoonotic CoV spike protein from the RsSHCO14-COV sequence that they isolated from the Chinese horseshoe bats.  They were exited that they were able to amplify the virus concluding “To extend these findings, primary human airways epithelial (HAE) cultures were infected and showed robust replication of both viruses.  Together, the data confirm the ability of viruses with the SHCO14 spike to infect human airway cells and underscore the potential threat of cross-species transmission of SHC014-CoV.” National Public Health 26552008

 

In 2015 - Gain-Of-Function Research Questioned

In 2015 VICE sounding the warning wrote – – According to [Dr. Ralph Baric, a professor of epidemiology at the University of North Carolina, Chapel Hill], the risk of “gain-of-function” research is worth it. The findings could provide a way to create vaccines and immunotherapy treatments before the next epidemic strikes. Because we have identified both SARS and SHC014-CoV, it’s now possible to develop vaccines that could target those viruses and the viruses that share commonalities between them. In other words, the new findings may help develop vaccines for many more strains of infectious diseases even though we haven’t identified them yet.

What Genius Thought That Creating Potential BioWeapons In The Chinese Communist Party's Backyard Was a Good Idea?

Who were these scientists?

Ralph S Baric

Department of Epidemiology, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill

Vineet D Menachery

Department of Epidemiology, University of North Carolina at Chapel Hill

Boyd L Yount, Jr.

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill

Xing-Yi Ge

Key Laboratory of Special Pathogens and Viosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.

Zhengli-Li Shi

Key Laboratory of Special Pathogens and Viosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.  Shi directs the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology.